82 results
Page 2 of 5
8-K
EX-99.1
m6htzp1h
29 Apr 22
Clinical - Stage Biopharmaceutical Company Focused on Next Generation Therapeutics Meeting Unmet Patient Needs APRIL 2022
4:16pm
424B5
c5gk722wuvjh6l 1n1
13 Apr 22
Prospectus supplement for primary offering
5:18pm
424B5
k5zy0g3 fv4k
11 Apr 22
Prospectus supplement for primary offering
5:31pm
8-K
EX-99.1
m2iu4gxquxh 9otwodzi
1 Sep 21
Clinical - Stage Biopharmaceutical Company Focused on Next Generation Therapeutics Meeting Unmet Patient Needs SEPTEMBER 2021
4:15pm
8-K
rwvda8aw
18 Jun 21
Other Events
12:00am
8-K
EX-99.2
oavdci0v6bh v9d1tzxc
24 May 21
Introduction to HT - KIT an mRNA Frame Shifting Therapeutic Significantly Inhibits Tumor Growth in Mast Cell - Derived Cancers
8:00am
8-K
EX-99.1
hs9 g5vlsut6
24 May 21
Introduction to HT - KIT an mRNA Frame Shifting Therapeutic Significantly Inhibits Tumor Growth in Mast Cell - Derived Cancers
8:00am
424B3
1yc4czsqbci6wwspv qo
6 Apr 21
Prospectus supplement
6:07am
424B3
k0wnb70 e1
19 Jan 21
Prospectus supplement
4:23pm
8-K
EX-99.1
nsb7acf2
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
4che r6awpt3e8x
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.1
l9q m5fwtw
31 Aug 20
Hoth Therapeutics Appoints Dr. Stefanie Johns, Ph.D., as Chief Scientific Officer
4:25pm